Document:

exhibit102bsondey

1  February 11, 2022  Dear Brian:  Re: Employment Agreement — Mutual Termination  As currently in effect, your Employment Agreement, dated November 3, 2004, with Triton International  Limited (the “Company”), is scheduled to expire on November 3, 2022.  Consistent with executive  compensation actions taken by many other companies, the Company has decided to cease the use of  employment agreements for executive officers.  You and the Company hereby mutually agree to terminate the Employment Agreement effective as of February  11, 2022.  You will continue to be employed as the Chief Executive Officer of the Company on an at-will basis.  The termination of the Employment Agreement will not result in a termination of your employment with the  Company, and will not be grounds for your resignation of employment for Good Reason, and you will not be  entitled to any payments or benefits under the Employment Agreement as a result of the termination of the  Employment Agreement.    It is understood that the severance benefits previously provided to you under the Employment Agreement will  be superseded by your participation in the Triton International Limited Executive Severance Plan (the “Plan”)  in the event of a qualifying termination under the Plan.    Sincerely,  /s/Chelsea Hogan  Name:  Chelsea Hogan  Title:  Senior Vice President, Chief Human Resources Officer  AGREED AND ACCEPTED  /s/Brian M. Sondey  Name: Brian M. Sondey  Exhibit 10.2Exhibit 4.3

 

Form of Warrant Agreement 

 

THE
REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES BY HIS, HER OR ITS ACCEPTANCE HEREOF, THAT SUCH HOLDER WILL NOT FOR A PERIOD OF ONE
HUNDRED EIGHTY (180) DAYS FOLLOWING THE COMMENCMENT OF SALES of COMMON SHARES IN THE OFFERING (AS DEFINED BELOW): (A) SELL, TRANSFER,
ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT TO ANYONE OTHER THAN OFFICERS OR PARTNERS OF BOUSTEAD securities, llc, EACH OF WHOM
SHALL HAVE AGREED TO THE RESTRICTIONS CONTAINED HEREIN, IN ACCORDANCE WITH FINRA CONDUCT RULE 5110(E)(1), OR (B) CAUSE THIS PURCHASE
WARRANT OR THE SECURITIES ISSUABLE HEREUNDER TO BE THE SUBJECT OF ANY HEDGING, SHORT SALE, DERIVATIVE, PUT OR CALL TRANSACTION THAT WOULD
RESULT IN THE EFFECTIVE ECONOMIC DISPOSITION OF THIS PURCHASE WARRANT OR THE SECURITIES HEREUNDER, EXCEPT AS PROVIDED FOR IN FINRA RULE
5110(E)(2).

 
THIS PURCHASE WARRANT IS NOT
EXERCISABLE PRIOR TO [*], 2022 (THE DATE OF ISSUANCE). VOID AFTER 5:00 P.M., EASTERN TIME, [*], 2027 (THE DATE THAT IS FIVE YEARS FROM
COMMENCMENT OF SALES of COMMON SHARES IN THE Offering (as defined below). 

 

COMMON SHARES PURCHASE WARRANT

 

For the Purchase of [*] Common Shares

 

Of

AKANDA CORP.

 
1.           Purchase
Warrant. THIS CERTIFIES THAT, pursuant to that certain Underwriting Agreement by and between Akanda Corp., a company incorporated
in the Province of Ontario (the “Company”) and Boustead Securities, LLC (“Boustead”), dated [*],
2022 (the “Underwriting Agreement”), Boustead (in such capacity with its permitted successors or assigns, the “Holder”),
as registered owner of this Purchase Warrant, is entitled, upon the terms and subject to the limitations on exercise and the conditions
hereinafter set forth, at any time or from time to time from [*], 2022 (the “Issuance Date”), and at or before 5:00
p.m., Eastern time, [*], 2027 (the “Expiration Date,”) which such date is five
(5) years from the commencement of the sales of the Common Shares in connection
with the initial public offering contemplated by the Underwriting Agreement (the “Offering”)
under the registration statement on Form F-1 (Registration No. 333-[*]) of the Company
(the “Registration Statement”), but not thereafter, to subscribe for, purchase and receive, in whole or
in part, up to [*] Common Shares of the Company, without par value (the “Shares”), subject to adjustment as provided
in Section 5 hereof. This Purchase Warrant is not exercisable or convertible for more than five years from the commencement
of sales of Common Shares in the Offering. If the Expiration Date is a day on which banking institutions are authorized by law or executive
order to close, then this Purchase Warrant may be exercised on the next succeeding day that is not such a day in accordance with the terms
herein. During the period commencing on the date hereof and ending on the Expiration Date, the Company agrees not to take any action that
would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[*] per Share (125% of the price of the Shares
sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 5 hereof,
the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such
exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or
the adjusted exercise price, depending on the context. Any term not defined herein shall have the meaning ascribed thereto in the Underwriting
Agreement.

 

2.           Exercise.

 

2.1          Exercise
Form. In order to exercise this Purchase Warrant, the exercise form attached hereto as Exhibit A (the “Exercise
Form”) must be duly executed and completed and delivered to the Company, together with this Purchase Warrant and payment of
the Exercise Price for the Shares being purchased payable in cash by wire transfer of immediately available funds to an account designated
by the Company or by certified check or official bank check to the order of the Company. If the subscription rights represented hereby
shall not be exercised at or before 5:00 p.m., Eastern time, on the Expiration Date, this Purchase Warrant shall become and be void without
further force or effect, and all rights represented hereby shall cease and expire.

 

     

     

    

 

2.2          Cashless
Exercise. In lieu of exercising this Purchase Warrant by payment of cash or check payable to the order of the Company pursuant to Section
2.1 above, Holder may elect to receive the number of Shares equal to the value of this Purchase Warrant (or the portion thereof
being exercised), by surrender of this Purchase Warrant to the Company, together with the Exercise Form, in which event the Company shall
issue to Holder, Shares in accordance with the following formula:

 

	    X   =	Y(A – B)
	A

  

	 	Where,	X   =    The number of Shares to be issued to Holder;
	 	 	Y   =    The number of Shares
for which the Purchase Warrant is being exercised;
	 	 	A   =    The fair market
value of one Share; and
	 	 	B   =    The Exercise Price.

 

For purposes of this Section
2.2, the fair market value means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common
Shares are then listed or quoted on a Eligible Market, the value shall be deemed to be the highest intra-day or closing price on any trading
day on such Eligible Market during the five trading days preceding the exercise, (b) if OTCQB or OTCQX is not an Eligible Market, the
value shall be deemed to be the highest intra-day or closing price on any trading day on the OTCQB or OTCQX on which the Common Shares
are then quoted during the five trading days preceding the exercise, as applicable, (c) if the Common Shares are not then listed or quoted
for trading on OTCQB or OTCQX and if prices for the Common Shares are then reported in the “Pink Sheets” published by OTC
Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the “OTC Markets Group”,
the value shall be deemed to be the highest intra-day or closing price on any trading day on the Pink Sheets on which the Common Shares
are then quoted during the five trading days preceding the exercise, or (d) in all other cases, the fair market value of a Common Share
as determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company. 

 

2.3       Legend.
Each certificate for the securities purchased under this Purchase Warrant shall bear a legend as
follows unless such securities have been registered under the Securities Act of 1933, as amended (the “Securities Act”):

 

“The securities
represented by this certificate have not been registered under the Securities Act of 1933, as amended (the “Securities Act”),
or applicable state law. Neither the securities nor any interest therein may be offered for sale, sold or otherwise transferred except
pursuant to an effective registration statement under the Securities Act, or pursuant to an exemption from registration under the Securities
Act and applicable state law which, in the opinion of counsel to the Company, is available.”

 

3.           Transfer.

 
3.1          General
Restrictions. The Holder of this Purchase Warrant agrees by his, her or its acceptance hereof, that such Holder (or permitted assignees
under FINRA Rule 5110(e)(1)) will not for a period of one hundred eighty (180) days following the commencement
of the sales of the Common Shares in connection with the Offering (the “Effective Date”) by the Securities and
Exchange Commission (the “Commission”): (a) sell, transfer, assign, pledge or hypothecate this Purchase Warrant to
anyone other than: (i) Boustead or an underwriter, placement agent, or a selected dealer participating in the Offering, or (ii) officers
or partners of Boustead or of any such underwriter, placement agent or selected dealer, each of whom in (i) and (ii) shall have agreed
to the restrictions contained herein, in accordance with FINRA Conduct Rule 5110(e)(1), or (b) cause this Purchase Warrant or the
securities issuable hereunder to be the subject of any hedging, short sale, derivative, put or call transaction that would result in the
effective economic disposition of this Purchase Warrant or the securities hereunder, except as provided for in FINRA Rule 5110(e)(2).
On and after that date that is one hundred eighty (180) days after the Effective Date, transfers to others may be made subject to compliance
with or exemptions from applicable securities laws. In order to make any permitted assignment, the Holder must deliver to the Company
the assignment form attached hereto as Exhibit B duly executed and completed, together with this Purchase Warrant and
payment of all transfer taxes, if any, payable in connection therewith. The Company shall within five (5) business days transfer this
Purchase Warrant on the books of the Company and shall execute and deliver a new Purchase Warrant or Purchase Warrants of like tenor to
the appropriate assignee(s) expressly evidencing the right to purchase the aggregate number of Shares purchasable hereunder or such portion
of such number as shall be contemplated by any such assignment.

 

     

     

    

 

3.2          Restrictions
Imposed by the Securities Act. The securities evidenced by this Purchase Warrant shall not be transferred unless and until: (i) if
required by law, the Company has received the opinion of counsel for the Company that the securities may be transferred pursuant to an
exemption from registration under Securities Act and applicable state securities laws, or (ii) a registration statement or post-effective
amendment to the Registration Statement relating to the offer and sale of such securities that includes a current prospectus has been
filed and declared effective by the Commission and compliance with applicable state securities law has been established.

 

4.           New
Purchase Warrants to be Issued.

 

4.1          Partial
Exercise or Transfer. Subject to the restrictions in Section 3 hereof, this Purchase Warrant may be exercised or
assigned in whole or in part. In the event of the exercise or assignment hereof in part only, upon surrender of this Purchase Warrant
for cancellation, together with the duly executed exercise or assignment form and funds sufficient to pay any Exercise Price and/or transfer
tax if exercised pursuant to Section 2.1 hereof, the Company shall cause to be delivered to the Holder without charge
a new Purchase Warrant of like tenor to this Purchase Warrant in the name of the Holder evidencing the right of the Holder to purchase
the number of Shares purchasable hereunder as to which this Purchase Warrant has not been exercised or assigned.

 

4.2          Lost
Certificate. Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction or mutilation of this Purchase
Warrant and of reasonably satisfactory indemnification or the posting of a bond, the Company shall execute and deliver a new Purchase
Warrant of like tenor and date. Any such new Purchase Warrant executed and delivered as a result of such loss, theft, mutilation or destruction
shall constitute a substitute contractual obligation on the part of the Company.

 

5.           Adjustments.

 

5.1          Adjustments
to Exercise Price and Number of Shares. The Exercise Price and the number of Shares underlying this Purchase Warrant shall be subject
to adjustment from time to time as hereinafter set forth:

 

5.1.1       Share
Dividends; Split Ups. If, after the date hereof, and subject to the provisions of Section 5.1.3 below, the number
of outstanding Shares is increased by a stock dividend payable in Shares or by a split up of Shares or other similar event, then, on the
effective day thereof, the number of Shares purchasable hereunder shall be increased in proportion to such increase in outstanding shares,
and the Exercise Price shall be proportionately decreased.

 

5.1.2       Aggregation
of Shares. If, after the date hereof, and subject to the provisions of Section 5.1.3 below, the number of outstanding
Shares is decreased by a consolidation, combination or reclassification of Shares or other similar event, then, on the effective date
thereof, the number of Shares purchasable hereunder shall be decreased in proportion to such decrease in outstanding shares, and the Exercise
Price shall be proportionately increased.

 

5.1.3       Replacement
of Shares upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding Shares other than a
change covered by Section 5.1.1 or Section 5.1.2 hereof or that solely affects the par value
of such Shares, or in the case of any share reconstruction or amalgamation or merger or consolidation of the Company with or into
another corporation (other than a consolidation or share reconstruction or amalgamation or merger in which the Company is the
continuing corporation and that does not result in any reclassification or reorganization of the outstanding Shares), or in the case
of any sale or conveyance to another corporation or entity of the property of the Company as an entirety or substantially as an
entirety in connection with which the Company is dissolved, the Holder of this Purchase Warrant shall have the right thereafter
(until the expiration of the right of exercise of this Purchase Warrant) to receive upon the exercise hereof, for the same aggregate
Exercise Price payable hereunder immediately prior to such event, the kind and amount of shares of stock or other securities or
property (including cash) receivable upon such reclassification, reorganization, share reconstruction or amalgamation or merger, or
consolidation, or upon a dissolution following any such sale or transfer, by a Holder of the number of Shares of the Company
obtainable upon exercise of this Purchase Warrant immediately prior to such event; and if any reclassification also results in a
change in Shares covered by Section 5.1.1 or Section 5.1.2, then such adjustment shall be made pursuant
to Section 5.1.1, Section 5.1.2 and this Section 5.1.3. The provisions of
this Section 5.1.3 shall similarly apply to successive reclassifications, reorganizations, share
reconstructions or amalgamations, mergers or consolidations, sales or other transfers.

 

     

     

    

   

5.1.4       Changes
in Form of Purchase Warrant. This form of Purchase Warrant need not be changed because of any change pursuant to this Section
5.1, and Purchase Warrants issued after such change may state the same Exercise Price and the same number of Shares as are stated
in the Purchase Warrants initially issued pursuant to this Agreement. The acceptance by any Holder of the issuance of new Purchase Warrants
reflecting a required or permissive change shall not be deemed to waive any rights to an adjustment occurring after the date hereof or
the computation thereof.

 

5.2          Substitute
Purchase Warrant. In case of any consolidation of the Company with, or share reconstruction or amalgamation or merger of the Company
with or into, another corporation (other than a consolidation or share reconstruction or amalgamation or merger which does not result
in any reclassification or change of the outstanding Shares), the corporation formed by such consolidation or share reconstruction or
amalgamation or merger shall execute and deliver to the Holder a supplemental Purchase Warrant providing that the holder of each Purchase
Warrant then outstanding or to be outstanding shall have the right thereafter (until the stated expiration of such Purchase Warrant) to
receive, upon exercise of such Purchase Warrant, the kind and amount of shares of stock and other securities and property receivable upon
such consolidation or share reconstruction or amalgamation or merger, by a holder of the number of Shares of the Company for which such
Purchase Warrant might have been exercised immediately prior to such consolidation, share reconstruction or amalgamation or merger, sale
or transfer. Such supplemental Purchase Warrant shall provide for adjustments which shall be identical to the adjustments provided for
in this Section 5. The above provision of this Section 5 shall similarly apply to successive consolidations
or share reconstructions or amalgamations or mergers.

 

5.3          Elimination
of Fractional Interests. The Company shall not be required to issue certificates representing fractions of Shares upon the exercise
of the Purchase Warrant, nor shall it be required to issue scrip or pay cash in lieu of any fractional interests, it being the intent
of the parties that all fractional interests shall be eliminated by rounding any fraction up or down, as the case may be, to the nearest
whole number of Shares or other securities, properties or rights.

 

6.           Reservation
and Listing. The Company shall at all times reserve and keep available out of its authorized Shares, solely for the purpose of issuance
upon exercise of this Purchase Warrant, such number of Shares or other securities, properties or rights as shall be issuable upon the
exercise thereof. The Company covenants and agrees that, upon exercise of this Purchase Warrant and payment of the Exercise Price therefor,
in accordance with the terms hereby, all Shares and other securities issuable upon such exercise shall be duly and validly issued, fully
paid and non-assessable and not subject to preemptive rights of any shareholder. The Company further covenants and agrees that upon exercise
of this Purchase Warrant and payment of the exercise price therefor, all Shares and other securities issuable upon such exercise shall
be duly and validly issued, fully paid and non-assessable and not subject to preemptive rights of any shareholder. As long as this Purchase
Warrant shall be outstanding, the Company shall use its commercially reasonable efforts to cause all Shares issuable upon exercise of
this Purchase Warrant to be listed (subject to official notice of issuance) on all national securities exchanges (or, if applicable, on
the OTC Bulletin Board or any successor trading market) on which the Shares issued to the public in the Offering may then be listed and/or
quoted.

 

7.       Registration.
The issuance of the Warrant and the Warrant Shares has been registered on the Registration Statement. The Company shall file
periodic filings with the Commission during the term of this Purchase Warrant as required by the rules and regulations issued by the
Commission. To the extent the Company does not maintain an effective registration statement for the Shares, during the term of this
Purchase Warrant and for a period of no more than seven (7) years from the commencement of sales of the Offering in accordance with
FINRA Rule 5110(g)(8)(D), whenever the Company proposes to register any of its securities under the Securities Act, whether for its
own account or for the account of another shareholder (except for the registration of securities (A) to be offered pursuant to an
employee benefit plan on Form S-8 or (B) pursuant to a registration made on Form F-4, or any successor forms then in effect) at any
time and the registration form to be used may be used for the registration of the Shares, it will so notify in writing the Holder (a
 “Piggyback Notice”) as soon as practicable but in no event less than five (5) business days before
the anticipated filing date and offer to the Holder the opportunity to register the sale of such number of Shares as such Holder may
request in writing within three (3) business days after receipt of such Piggyback Notice (a “Piggyback
Registration”). Notwithstanding the foregoing, the Company may delay any such notice to the Holder, including until
after filing a registration statement, so long as the Holder has the same amount of time to determine whether to participate in an
offering as it would have had if such notice had not been so delayed. The Company shall cause such Shares to be included in such
registration and shall use commercially reasonable efforts to cause the managing underwriter or underwriters of a proposed
underwritten offering to permit the Shares requested to be included in a Piggyback Registration on the same terms and conditions as
any similar securities of the Company and to permit the sale or other disposition of such Shares in accordance with the intended
method(s) of distribution thereof; provided, however, that if, solely in connection with any primary underwritten public offering
for the account of the Company, the managing underwriter(s) thereof shall, in its reasonable discretion, impose a limitation on the
number of Common Shares which may be included in the registration statement because, in such underwriter(s)’ judgment,
marketing or other factors dictate such limitation is necessary to facilitate public distribution, then the Company shall be
obligated to include in such registration statement only such limited portion of the Shares with respect to which the Holder
requested inclusion hereunder as the underwriter shall reasonably permit. Holder shall enter into an underwriting agreement in
customary form with the underwriter or underwriters selected for such Piggyback Registration.

 

     

     

    

 

8.           Certain
Notice Requirements.

 

8.1          Holder’s
Right to Receive Notice. Nothing herein shall be construed as conferring upon the Holders the right to vote or consent or to receive
notice as a shareholder for the election of directors or any other matter, or as having any rights whatsoever as a shareholder of the
Company. If, however, at any time prior to the expiration of the Purchase Warrants and their exercise, any of the events described in Section
8.2 shall occur, then, in one or more of said events, the Company shall give written notice of such event at least fifteen days
prior to the date fixed as a record date or the date of closing the transfer books (the “Notice Date”) for the determination
of the shareholders entitled to such dividend, distribution, conversion or exchange of securities or subscription rights, or entitled
to vote on such proposed dissolution, liquidation, winding up or sale. Such notice shall specify such record date or the date of the closing
of the transfer books, as the case may be. Notwithstanding the foregoing, the Company shall deliver to each Holder a copy of each notice
given to the other shareholders of the Company at the same time and in the same manner that such notice is given to the shareholders.

 

8.2          Events
Requiring Notice. The Company shall be required to give the notice described in this Section 8 upon one or more of
the following events: (i) if the Company shall take a record of the holders of its Shares for the purpose of entitling them to receive
a dividend or distribution payable otherwise than in cash, or a cash dividend or distribution payable otherwise than out of retained earnings,
as indicated by the accounting treatment of such dividend or distribution on the books of the Company, (ii) the Company shall offer to
all the holders of its Shares any additional shares of capital stock of the Company or securities convertible into or exchangeable for
shares of capital stock of the Company, or any option, right or warrant to subscribe therefor, or (iii) a dissolution, liquidation or
winding up of the Company (other than in connection with a consolidation or share reconstruction or amalgamation or merger) or a sale
of all or substantially all of its property, assets and business shall be proposed.

 

8.3          Notice
of Change in Exercise Price. The Company shall, promptly after an event requiring a change in the Exercise Price pursuant to Section
5 hereof, send notice to the Holders of such event and change (“Price Notice”). The Price Notice shall describe
the event causing the change and the method of calculating same and shall be certified as being true and accurate by the Company’s
Chief Financial Officer.

 

     

     

    

 

8.4          Transmittal
of Notices. All notices, requests, consents and other communications under this Purchase Warrant shall be in writing and shall be
deemed to have been duly made (1) when hand delivered, (2) when mailed by express mail or private courier service or (3) when the
event requiring notice is disclosed in all material respects and filed in a current report on Form 8-K (or similar report of the Company
required of foreign private issuers) or in a definitive proxy statement on Schedule 14A prior to the Notice Date: (i) if to the registered
Holder of the Purchase Warrant, to the address of such Holder as shown on the books of the Company, or (ii) if to the Company, to following
address or to such other address as the Company may designate by notice to the Holders:

  

If to the Holder:

 

Boustead Securities, LLC

6 Venture, Suite 395

Irvine, CA 92618

Fax: (815) 301-8099

Attention: Keith Moore, CEO

 

with a copy (which shall
not constitute notice) to:

 

BEVILACQUA PLLC

1050 Connecticut Avenue, Suite 500

Washington, DC 20036

Fax: (202) 869-0889

Attn: Louis A. Bevilacqua, Esq.

 

If to the Company:

 

Akanda Corp.

1a, 1b Learoyd Road

New Romney TN28
8XU, United Kingdom

Fax: [*]

Attention: Tejinder
Virk, CEO

 

with copies (which shall
not constitute notice) to:

 

Rimon, P.C.

423 Washington Street, Suite 600

San Francisco, California 94111

Fax: [*]

Attn: Mark C. Lee

 

Eric Foster Dentons Canada LLP

77 King Street West, Suite 400

Toronto-Dominion Centre

Toronto, ON M5K 0A1 Canada

Fax: [*]

Attn: [*]

 

9.           Miscellaneous.

 

9.1          Amendments.
The Company and Boustead may from time to time supplement or amend this Purchase Warrant without the approval of any of the Holders in
order to cure any ambiguity, to correct or supplement any provision contained herein that may be defective or inconsistent with any other
provisions herein, or to make any other provisions in regard to matters or questions arising hereunder that the Company and Boustead may
deem necessary or desirable and that the Company and Boustead deem shall not adversely affect the interest of the Holders. All other modifications
or amendments shall require the written consent of and be signed by the party against whom enforcement of the modification or amendment
is sought.

 

9.2          Headings.
The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or affect the meaning
or interpretation of any of the terms or provisions of this Purchase Warrant.

   

9.3          Entire
Agreement. This Purchase Warrant (together with the other agreements and documents being delivered pursuant to or in connection
with this Purchase Warrant) constitutes the entire agreement of the parties hereto with respect to the subject matter hereof, and
supersedes all prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof.

 

     

     

    

 

9.4          Binding
Effect. This Purchase Warrant shall inure solely to the benefit of and shall be binding upon, the Holder and the Company and their
permitted assignees, respective successors, legal representatives and assigns, and no other person shall have or be construed to have
any legal or equitable right, remedy or claim under or in respect of or by virtue of this Purchase Warrant or any provisions herein contained.

 

9.5          Governing
Law; Submission to Jurisdiction; Trial by Jury. This Purchase Warrant shall be governed by and construed and enforced in accordance
with the laws of the State of California, without giving effect to conflict of laws principles thereof. The Company hereby agrees that
any action, proceeding or claim against it arising out of, or relating in any way to this Purchase Warrant shall be brought and enforced
in the courts located in Los Angeles, California, or in the United States District Court located in Los Angeles, California, and irrevocably
submits to such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction
and that such courts represent an inconvenient forum. Any process or summons to be served upon the Company may be served by transmitting
a copy thereof by registered or certified mail, return receipt requested, postage prepaid, addressed to it at the address set forth in Section
8 hereof. Such mailing shall be deemed personal service and shall be legal and binding upon the Company in any action, proceeding
or claim. The Company and the Holder agree that the prevailing party(ies) in any such action shall be entitled to recover from the other
party(ies) all of its reasonable attorneys’ fees and expenses relating to such action or proceeding and/or incurred in connection
with the preparation therefor. The Company (on its behalf and, to the extent permitted by applicable law, on behalf of its stockholders
and affiliates) and the Holder hereby irrevocably waive, to the fullest extent permitted by applicable law, any and all right to trial
by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.

 

9.6          Waiver,
etc. The failure of the Company or the Holder to at any time enforce any of the provisions of this Purchase Warrant shall not be deemed
or construed to be a waiver of any such provision, nor to in any way affect the validity of this Purchase Warrant or any provision hereof
or the right of the Company or any Holder to thereafter enforce each and every provision of this Purchase Warrant. No waiver of any breach,
non-compliance or non-fulfillment of any of the provisions of this Purchase Warrant shall be effective unless set forth in a written instrument
executed by the party or parties against whom or which enforcement of such waiver is sought; and no waiver of any such breach, non-compliance
or non-fulfillment shall be construed or deemed to be a waiver of any other or subsequent breach, non-compliance or non-fulfillment.

 

9.7          Exchange
Agreement. As a condition of the Holder’s receipt and acceptance of this Purchase Warrant, Holder agrees that, at any time prior
to the complete exercise of this Purchase Warrant by Holder, if the Company and Boustead enter into an agreement (“Exchange Agreement”)
pursuant to which they agree that all outstanding Purchase Warrants will be exchanged for securities or cash or a combination of both,
then Holder shall agree to such exchange and become a party to the Exchange Agreement.

 

9.8          Execution
in Counterparts. This Purchase Warrant may be executed in two (2) or more counterparts, each of which shall be deemed an original,
but all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including
pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission
method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.

 

[Remainder of page intentionally left blank.] 

 

     

     

    

 

IN WITNESS WHEREOF, the Company has caused this Purchase Warrant
to be signed by its duly authorized officer as of [*], 2022. 

 

	AKANDA CORP.	 
	 	 	 
	By:	 	 
	 	Name: Tejinder Virk	 
	 	Title: Chief Executive Officer	 

 

     

     

    

 

EXHIBIT A

 

Form to be used to exercise Purchase Warrant:

 

Date: __________, 20___

 

The undersigned hereby elects
irrevocably to exercise the Purchase Warrant for ______ Shares of Akanda Corp., a company incorporated in the Province of Ontario (the
 “Company”) and hereby makes payment of $____ (at the rate of $____ per Share) in payment of the Exercise Price pursuant
thereto. Please issue the Shares as to which this Purchase Warrant is exercised in accordance with the instructions given below and, if
applicable, a new Purchase Warrant representing the number of Shares for which this Purchase Warrant has not been exercised.

 

or

 

The undersigned hereby elects
irrevocably to convert its right to purchase ___ Shares under the Purchase Warrant for ______ Shares, as determined in accordance with
the following formula:

 

	X	=	Y(A-B)
	 	 	A

 

	 	Where,	X   =   The number of Shares to be issued to Holder;
	 	 	Y   =   The number of Shares
for which the Purchase Warrant is being exercised;
	 	 	A   =   The fair market value
(defined in Section 2.2 of the Purchase Warrant) of one Share which is equal to $_____; and
	 	 	B   =   The Exercise Price which
is equal to $______ per share

 

The undersigned agrees and
acknowledges that the calculation set forth above is subject to confirmation by the Company and any disagreement with respect to the calculation
shall be resolved by the Company in its sole discretion.

 

Please issue the Shares
as to which this Purchase Warrant is exercised in accordance with the instructions given below and, if applicable, a new Purchase Warrant
representing the number of Shares for which this Purchase Warrant has not been exercised. 

 

	
	 	 
	Signature	 
	 	 
	
	Name/Title 	 

 

     

     

    

 

INSTRUCTIONS FOR REGISTRATION OF SECURITIES

 

Delivery of Warrant Shares.
The Company shall deliver to Holder, or its designee or agent as specified below, __________ Warrant Shares in accordance with the terms
of the Warrant. Delivery shall be made to Holder, or for its benefit, as follows:

 

__ Check here if requesting
delivery as a certificate to the following name and to the following address:

 

	Issue to:	 
	 	 
	 	 

  

__ Check here if requesting delivery by
Deposit/Withdrawal at Custodian as follows:

 

	DTC Participant:	 
	DTC Number:	 
	Account Number:	 
	 	 	 

	
    Date: _____________ __, 

     
	 
	 	 
	Name of Registered Holder	 

 

	 	 
	By:	 	 
	 	Name:	 
	 	Title:	 

 

	 	Tax ID:                                             	 

 

	 	Electronic Mail :                                    	 

 

     

     

    

 

EXHIBIT B

 

Form to be used to assign Purchase Warrant:

 

(To be executed by the registered
Holder to effect a transfer of the within Purchase Warrant):

 

FOR VALUE RECEIVED,                                            does
hereby sell, assign and transfer unto the right to purchase shares of Akanda Corp., a company incorporated in the Province of Ontario
(the “Company”), evidenced by the Purchase Warrant and does hereby authorize the Company to transfer such right on
the books of the Company.

 

Dated:  ____________, 20__

 

Signature

 

NOTICE: The signature to
this form must correspond with the name as written upon the face of the within Purchase Warrant without alteration or enlargement or any
change whatsoever.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}]]